P1342: A SCREENING TOOL TO DETECT CHRONIC OCULAR GRAFT VERSUS HOST DISEASE IN A HEMATOLOGY/ONCOLOGY OUTPATIENT SETTING

JN Gabhann-Dromgoole - HemaSphere, 2022 - journals.lww.com
Background: Chronic ocular GvHD (oGvHD) is reported to occur in 30-60% of patients after
hematological stem cell transplantation (HSCT). Presently, there is no diagnostic test …
相关文章

P1342: A SCREENING TOOL TO DETECT CHRONIC OCULAR GRAFT VERSUS HOST DISEASE IN A HEMATOLOGY/ONCOLOGY OUTPATIENT SETTING

E Greenan, E Vandenberghe, E Conneally… - …, 2022 - europepmc.org
Background: Chronic ocular GvHD (oGvHD) is reported to occur in 30-60% of patients after
hematological stem cell transplantation (HSCT). Presently, there is no diagnostic test …

P1342: A SCREENING TOOL TO DETECT CHRONIC OCULAR GRAFT VERSUS HOST DISEASE IN A HEMATOLOGY/ONCOLOGY OUTPATIENT SETTING

E Greenan, E Vandenberghe, E Conneally… - …, 2022 - ncbi.nlm.nih.gov
Background: Chronic ocular GvHD (oGvHD) is reported to occur in 30-60% of patients after
hematological stem cell transplantation (HSCT). Presently, there is no diagnostic test …

[引用][C] P1342: A SCREENING TOOL TO DETECT CHRONIC OCULAR GRAFT VERSUS HOST DISEASE IN A HEMATOLOGY/ONCOLOGY OUTPATIENT SETTING

E Greenan, E Vandenberghe, E Conneally… - …, 2022 - Wiley Online Library
Background: Chronic ocular GvHD (oGvHD) is reported to occur in 30-60% of patients after
hematological stem cell transplantation (HSCT). Presently, there is no diagnostic test …